Citations (0)
Keep up to date with the latest research on this topic with citation updates for this article.
Leukemia & Lymphoma
Volume 65, 2024 - Issue 6
Original Articles
An open-label phase 2 study treating patients with first or second relapse of multiple myeloma with carfilzomib, pomalidomide, and dexamethasone (KPd): SELECT study
Aurore Perrota Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France
https://orcid.org/0000-0003-0131-8689View further author information
https://orcid.org/0000-0003-0131-8689View further author information, Sosana Delimpasib General Hospital Evangelismos, Athens, Greecehttps://orcid.org/0000-0001-7523-7510View further author information
https://orcid.org/0000-0001-7523-7510View further author information, Emmanouil Spanoudakisc University General Hospital of Evros-Alexandroupolis District, Alexandroupolis, Greecehttps://orcid.org/0000-0003-4985-5862View further author information
https://orcid.org/0000-0003-4985-5862View further author information, , , Albert Oriolf Hematology Department, Insitut Català d’Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spainhttps://orcid.org/0000-0001-6804-2221View further author information
https://orcid.org/0000-0001-6804-2221View further author information, Philippe Moreaug Hematology Department, University Hospital, Nantes, Francehttps://orcid.org/0000-0003-1780-8746View further author information
https://orcid.org/0000-0003-1780-8746View further author information, Ian McFaddenh Amgen Inc., Thousand Oaks, CA, USAhttps://orcid.org/0009-0004-7488-8804View further author information
https://orcid.org/0009-0004-7488-8804View further author information, Qing Xiah Amgen Inc., Thousand Oaks, CA, USAhttps://orcid.org/0009-0007-4120-2740View further author information
https://orcid.org/0009-0007-4120-2740View further author information, Mukta Arorah Amgen Inc., Thousand Oaks, CA, USAhttps://orcid.org/0000-0001-9362-0556View further author information
https://orcid.org/0000-0001-9362-0556View further author information & Meletios Athanasios Dimopoulosi Section of Hematology and Medical Oncology, Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Alexandra Hospital, Athens, GreeceCorrespondence[email protected]
https://orcid.org/0000-0001-8990-3254View further author information
https://orcid.org/0000-0001-8990-3254View further author information show all